Cargando…

Identification of Factors Related to the Quality of Lymphadenectomy for Lung Cancer: Secondary Analysis of Prospective Randomized Trial Data

The outcomes of non-small cell lung cancer surgery are influenced by the quality of lymphadenectomy. This study aimed to evaluate the impact of different energy devices on lymphadenectomy quality and identify additional influencing factors. This secondary analysis of the prospective randomized trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabryel, Piotr, Roszak, Magdalena, Skrzypczak, Piotr, Gabryel, Anna, Zielińska, Dominika, Sielewicz, Magdalena, Campisi, Alessio, Kasprzyk, Mariusz, Piwkowski, Cezary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253929/
https://www.ncbi.nlm.nih.gov/pubmed/37297976
http://dx.doi.org/10.3390/jcm12113780
_version_ 1785056523303518208
author Gabryel, Piotr
Roszak, Magdalena
Skrzypczak, Piotr
Gabryel, Anna
Zielińska, Dominika
Sielewicz, Magdalena
Campisi, Alessio
Kasprzyk, Mariusz
Piwkowski, Cezary
author_facet Gabryel, Piotr
Roszak, Magdalena
Skrzypczak, Piotr
Gabryel, Anna
Zielińska, Dominika
Sielewicz, Magdalena
Campisi, Alessio
Kasprzyk, Mariusz
Piwkowski, Cezary
author_sort Gabryel, Piotr
collection PubMed
description The outcomes of non-small cell lung cancer surgery are influenced by the quality of lymphadenectomy. This study aimed to evaluate the impact of different energy devices on lymphadenectomy quality and identify additional influencing factors. This secondary analysis of the prospective randomized trial data (clinicaltrials.gov: NCT03125798) compared patients who underwent thoracoscopic lobectomy with the LigaSure device (study group, n = 96) and monopolar device (control group, n = 94). The primary endpoint was the lobe-specific mediastinal lymphadenectomy. Lobe-specific mediastinal lymphadenectomy criteria were met in 60.4% and 38.3% of patients in the study and control groups, respectively (p = 0.002). In addition, in the study group, the median number of mediastinal lymph node stations removed was higher (4 vs. 3, p = 0.017), and complete resection was more often achieved (91.7% vs. 80.9%, p = 0.030). Logistic regression analysis indicated that lymphadenectomy quality was positively associated with the use of the LigaSure device (OR, 2.729; 95% CI, 1.446 to 5.152; p = 0.002) and female sex (OR, 2.012; 95% CI, 1.058 to 3.829; p = 0.033), but negatively associated with a higher Charlson Comorbidity Index (OR, 0.781; 95% CI, 0.620 to 0.986; p = 0.037), left lower lobectomy (OR, 0.263; 95% CI, 0.096 to 0.726; p = 0.010) and middle lobectomy (OR, 0.136; 95% CI, 0.031 to 0.606, p = 0.009). This study found that using the LigaSure device can improve the quality of lymphadenectomy in lung cancer patients and also identified other factors that affect the quality of lymphadenectomy. These findings contribute to improving lung cancer surgical treatment outcomes and provide valuable insights for clinical practice.
format Online
Article
Text
id pubmed-10253929
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102539292023-06-10 Identification of Factors Related to the Quality of Lymphadenectomy for Lung Cancer: Secondary Analysis of Prospective Randomized Trial Data Gabryel, Piotr Roszak, Magdalena Skrzypczak, Piotr Gabryel, Anna Zielińska, Dominika Sielewicz, Magdalena Campisi, Alessio Kasprzyk, Mariusz Piwkowski, Cezary J Clin Med Article The outcomes of non-small cell lung cancer surgery are influenced by the quality of lymphadenectomy. This study aimed to evaluate the impact of different energy devices on lymphadenectomy quality and identify additional influencing factors. This secondary analysis of the prospective randomized trial data (clinicaltrials.gov: NCT03125798) compared patients who underwent thoracoscopic lobectomy with the LigaSure device (study group, n = 96) and monopolar device (control group, n = 94). The primary endpoint was the lobe-specific mediastinal lymphadenectomy. Lobe-specific mediastinal lymphadenectomy criteria were met in 60.4% and 38.3% of patients in the study and control groups, respectively (p = 0.002). In addition, in the study group, the median number of mediastinal lymph node stations removed was higher (4 vs. 3, p = 0.017), and complete resection was more often achieved (91.7% vs. 80.9%, p = 0.030). Logistic regression analysis indicated that lymphadenectomy quality was positively associated with the use of the LigaSure device (OR, 2.729; 95% CI, 1.446 to 5.152; p = 0.002) and female sex (OR, 2.012; 95% CI, 1.058 to 3.829; p = 0.033), but negatively associated with a higher Charlson Comorbidity Index (OR, 0.781; 95% CI, 0.620 to 0.986; p = 0.037), left lower lobectomy (OR, 0.263; 95% CI, 0.096 to 0.726; p = 0.010) and middle lobectomy (OR, 0.136; 95% CI, 0.031 to 0.606, p = 0.009). This study found that using the LigaSure device can improve the quality of lymphadenectomy in lung cancer patients and also identified other factors that affect the quality of lymphadenectomy. These findings contribute to improving lung cancer surgical treatment outcomes and provide valuable insights for clinical practice. MDPI 2023-05-31 /pmc/articles/PMC10253929/ /pubmed/37297976 http://dx.doi.org/10.3390/jcm12113780 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gabryel, Piotr
Roszak, Magdalena
Skrzypczak, Piotr
Gabryel, Anna
Zielińska, Dominika
Sielewicz, Magdalena
Campisi, Alessio
Kasprzyk, Mariusz
Piwkowski, Cezary
Identification of Factors Related to the Quality of Lymphadenectomy for Lung Cancer: Secondary Analysis of Prospective Randomized Trial Data
title Identification of Factors Related to the Quality of Lymphadenectomy for Lung Cancer: Secondary Analysis of Prospective Randomized Trial Data
title_full Identification of Factors Related to the Quality of Lymphadenectomy for Lung Cancer: Secondary Analysis of Prospective Randomized Trial Data
title_fullStr Identification of Factors Related to the Quality of Lymphadenectomy for Lung Cancer: Secondary Analysis of Prospective Randomized Trial Data
title_full_unstemmed Identification of Factors Related to the Quality of Lymphadenectomy for Lung Cancer: Secondary Analysis of Prospective Randomized Trial Data
title_short Identification of Factors Related to the Quality of Lymphadenectomy for Lung Cancer: Secondary Analysis of Prospective Randomized Trial Data
title_sort identification of factors related to the quality of lymphadenectomy for lung cancer: secondary analysis of prospective randomized trial data
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253929/
https://www.ncbi.nlm.nih.gov/pubmed/37297976
http://dx.doi.org/10.3390/jcm12113780
work_keys_str_mv AT gabryelpiotr identificationoffactorsrelatedtothequalityoflymphadenectomyforlungcancersecondaryanalysisofprospectiverandomizedtrialdata
AT roszakmagdalena identificationoffactorsrelatedtothequalityoflymphadenectomyforlungcancersecondaryanalysisofprospectiverandomizedtrialdata
AT skrzypczakpiotr identificationoffactorsrelatedtothequalityoflymphadenectomyforlungcancersecondaryanalysisofprospectiverandomizedtrialdata
AT gabryelanna identificationoffactorsrelatedtothequalityoflymphadenectomyforlungcancersecondaryanalysisofprospectiverandomizedtrialdata
AT zielinskadominika identificationoffactorsrelatedtothequalityoflymphadenectomyforlungcancersecondaryanalysisofprospectiverandomizedtrialdata
AT sielewiczmagdalena identificationoffactorsrelatedtothequalityoflymphadenectomyforlungcancersecondaryanalysisofprospectiverandomizedtrialdata
AT campisialessio identificationoffactorsrelatedtothequalityoflymphadenectomyforlungcancersecondaryanalysisofprospectiverandomizedtrialdata
AT kasprzykmariusz identificationoffactorsrelatedtothequalityoflymphadenectomyforlungcancersecondaryanalysisofprospectiverandomizedtrialdata
AT piwkowskicezary identificationoffactorsrelatedtothequalityoflymphadenectomyforlungcancersecondaryanalysisofprospectiverandomizedtrialdata